Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published May 21, 2016 | Published + Supplemental Material
Journal Article Open

Evaluating 3D printing to solve the sample-to-device interface for LRS and POC diagnostics: example of an interlock meter-mix device for metering and lysing clinical urine samples

Abstract

This paper evaluates the potential of 3D printing, a semi-automated additive prototyping technology, as a means to design and prototype a sample-to-device interface, amenable to diagnostics in limited-resource settings, where speed, accuracy and user-friendly design are critical components. As a test case, we built and validated an interlock meter-mix device for accurately metering and lysing human urine samples for use in downstream nucleic acid amplification. Two plungers and a multivalve generated and controlled fluid flow through the device and demonstrate the utility of 3D printing to create leak-free seals. Device operation consists of three simple steps that must be performed sequentially, eliminating manual pipetting and vortexing to provide rapid (5 to 10 s) and accurate metering and mixing. Bretherton's prediction was applied, using the bond number to guide a design that prevents potentially biohazardous samples from leaking from the device. We employed multi-material 3D printing technology, which allows composites with rigid and elastomeric properties to be printed as a single part. To validate the meter-mix device with a clinically relevant sample, we used urine spiked with inactivated Chlamydia trachomatis and Neisseria gonorrhoeae. A downstream nucleic acid amplification by quantitative PCR (qPCR) confirmed there was no statistically significant difference between samples metered and mixed using the standard protocol and those prepared with the meter-mix device, showing the 3D-printed device could accurately meter, mix and dispense a human urine sample without loss of nucleic acids. Although there are some limitations to 3D printing capabilities (e.g. dimension limitations related to support material used in the printing process), the advantages of customizability, modularity and rapid prototyping illustrate the utility of 3D printing for developing sample-to-device interfaces for diagnostics.

Additional Information

© 2016 The Royal Society of Chemistry. This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Received 01 Mar 2016, Accepted 18 Apr 2016. First published online 28 Apr 2016. This article is part of themed collection: 3D Printing and Open access articles from Lab on a Chip. This research was supported by DARPA Cooperative Agreement HR0011-11-2-0006. The content of this article does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. This material is also based upon work supported by National Science Foundation Graduate Research Fellowships DGE-1144469 (to E. J.). R. F. I. holds an Innovation in Regulatory Science Award from BWF. We thank Natasha Shelby for contributions to writing and editing this manuscript.

Attached Files

Published - c6lc00292g.pdf

Supplemental Material - c6lc00292g1.mp4

Files

c6lc00292g.pdf
Files (8.4 MB)
Name Size Download all
md5:50be61d4018b1410e794bd4edec55333
5.7 MB Download
md5:e57acbb01db99d1efe5f2ee0542a24a4
2.7 MB Preview Download

Additional details

Created:
August 20, 2023
Modified:
October 18, 2023